Synthetic-biology derived drugs
Active ingredients and adjuvants made by engineered cells instead of chemical synthesis — chassis cells, designed pathways, industrial fermentation and purification — with a 116,000-litre commercial-scale run reported in 2023.
1 · What it gives
Synthetic biology designs engineered biological systems for specific purposes, from simple modular units to complex genetic circuits. For drugs, it replaces conventional chemical synthesis that often needs costly reagents, severe conditions and long routes. Antheia completed a 116,000-litre commercial-scale fermentation run in 2023; the global synthetic biology market was valued at USD 9.5 billion in 2021 and is expected to reach USD 37 billion by 2026 (a forecast from the cited paper).
2 · What it replaces 6
| D3 | Fermentation-produced vitamins (B2, B12, C routes) instead of multi-step chemical synthesis Replaces: Chemical vitamin synthesis — Reichstein process for vitamin C (six chemical steps + one fermentation), chemical B2 routes (abandoned), … | FOOD |
| D2 | Industrial biocatalysis (enzymes and whole cells) — e.g. nitrile hydratase for acrylamide, engineered transaminase for sitagliptin, enzymatic antibiotic side-chain processes — instead of heavy-metal catalysts, high-pressure hydrogenation and multistep chemistry with toxic reagents Replaces: Copper-catalysed sulfuric-acid hydration of acrylonitrile; rhodium-catalysed high-pressure asymmetric hydrogenation; chemical deacylation of … | CHEM |
| D3 | Riboflavin (vitamin B2) by fermentation instead of multi-step chemical synthesis Replaces: Multi-step chemical synthesis of riboflavin from glucose-derived ribose and xylidine (dominant until the 1990s) | FOOD |
| D1 | Biosurfactants (rhamnolipids, sophorolipids) instead of petrochemical surfactants in cleaning and industrial formulation Replaces: Petrochemical surfactants in cleaners and formulations - linear alkylbenzene sulfonate (LAS), alcohol ethoxylates (AEO), alkylphenol … | CHEM |
| D3 | Glutamate and MSG by bacterial fermentation instead of protein hydrolysis and chemical synthesis Replaces: Hydrolysis of wheat gluten or soybean protein with hydrochloric acid (1909–1960s); acrylonitrile-based chemical synthesis (Japan, … | FOOD |
| D1 | Acid mine drainage and metal-rich mine water treatment with passive biological systems — sulfate-reducing bioreactors, compost wetlands, aerobic wetlands — instead of perpetual lime dosing Replaces: Active chemical treatment with lime/caustic soda (high-volume metal hydroxide sludge, continuous chemical and energy use), or no treatment … | SERV |
3 · How to implement 4 steps
- 1Engineer the chassisManipulate chassis cells.
- 2Build the pathwayConstruct and integrate the synthesis pathway and regulate the metabolic network.
- 3Industrial fermentationScale to industrial fermentation.
- 4PurifyPurify the product.
4 · Who delivers
Matched suppliers (matched automatically)
| Fermenstation | Japan | Producer | active |
| BM GreenTech Berhad | Malaysia | Research / RTO | active |
| GEA Group | Germany | Distributor | active |
| QINGDAO SEAWIN BIOTECH GROUP | China | Research / RTO | active |
| Tsingke Biotechnology | China | Producer | active |
| Ajinomoto | Japan | Producer | active |
| Alfa Laval | Sweden | Producer | active |
| Alterpacks | Singapore | Producer | active |
| Amano Enzyme | Japan | Producer | active |
| CJ CheilJedang (CJ Biomaterials) | South Korea | Producer | active |
| GenScript ProBio / Genscript | China | Research / RTO | active |
| Jiangsu Jland Biotech | China | Producer | active |
Leading companies and institutes (from the brief)
Antheia and SaponiQx are named as companies using synthetic biology for pharmaceutical ingredients or adjuvants. Others are matched by the portal under Pharma & biologics and Biofoundries.
5 · Rules & route to market
declaration of conformity, or SGR within 30 calendar days for new/specialized ingredients (plus tests)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
In the US, recombinant live biotherapeutic products are regulated by the FDA through the Center for Biologics Evaluation and Research (CBER).
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
The sources reviewed on 2026-10-16 identified no China regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
6 · Money: tenders & grants
7 · Tech stack & innovations
Main risks from the sources: inability to prove quality control (CMC issues), off-target effects and possible horizontal gene transfer.
Sources 5
- Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
- Lifescience.sinh.ac.cn — lifescience.sinh.ac.cn 2026-10-16
- Doi.org — doi.org 2026-10-16
- Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
- Pharm.jgvogel.cn — pharm.jgvogel.cn 2026-10-16